(PharmaNewsWire.Com, May 01, 2017 ) Middle-East and Africa Biosimilars Market research report, published by Market Data Forecastestimates that the market is growing with a CAGR of 32% to reach USD 1.63 billion by 2021, from USD 0.37 billion in 2016.
A Biosimilar is a biological medical product which is the best duplicate of an original product that is manufactured by some other company. When the patent of an original product expires, biosimilars can be manufacture with the approval of original innovator of those products.
The process of approval is on the basis of demonstration of comparing the similar product with the existing approved product and through a large number of clinical trials in patients. Biosimilars Market report are complex with potential structural variations and difficulty to differentiate the products. Theres a high potential of adverse immune reaction. The price of biosimilar products varies from 65-85% of its original product cost. Globally, the biosimilars market is expected to reach USD 35 billion by 2020.
Key factors which affect and thereby shift the market dynamics are studied intrinsically and are presented in an illustrious way in the report. Some of those factors are Adoption of western culture, Increase in diabetic diseases, Rise in cancer related mortality, Huge expenditure in biological therapies, Clinical trials are underway in many countries.
For granular level understanding the BiosimilarsMarket is segmented based on type, technology and application, each being provided with Market Size Estimations and Y-o-Y Forecasts. Based on Type: Protein Insulin Human Growth Hormones Granulocyte Colony-stimulating Factor (G-CSF) Interferons Recombinant Glycosylated Proteins Erythropoietin Monoclonal Antibodies Follitropin Recombinant Peptides Glucagon Calcitonin
Based on Technology: Mass Spectroscopy Chromatography Monoclonal Antibody Technology Recombinant DNA Technology Nuclear magnetic resonance (NMR) technology Electrophoresis Bioassay Based on Application: Oncology diseases Blood disorders Growth hormone deficiencies Chronic and autoimmune diseases Others
The Middle-East and Africa market is also analyzed individually in both the regions, thereby providing a more detailed geographical understanding of the market. Some of the major countries that hold significant place in this market include Egypt, KSA, Jordan, UAE, Nigeria and Algeria.
Some of the key players that operate in the Global Biosimilarsmarket includeDr. Reddys Laboratories,Wockhardt Ltd, Biocon Limited and CiplaLtd.. Jordan is leading with the approval of first biosimilar products within the region. The Middle-East and AfricaBiosimilarsmarket report offers wide-range of scope: Regional level analysis that provides an individual perspective of Middle-East and Africa region individually and on a whole Know more about key areas of industry growth via detailedSegment-level analysis on basis of type, technology, application, along with market size forecasts and y-o-y estimations Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics Strategic Analyses containingPESTLE and Porters Five Forces Analyseswhich are obtained by studying the macro & micro environmental factors that affect the market demographics Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Market Outlook - Investment opportunitiesdevised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Pharmaceuticals Market:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
